(Q48597328)

13 February 2018

title

Diagnosis and treatment of acromegaly complications. (English)

1 reference

13 February 2018

15

M L Vance

1 reference

13 February 2018

author name string

A Giustina

1

1 reference

13 February 2018

F F Casanueva

2

1 reference

13 February 2018

F Cavagnini

3

1 reference

13 February 2018

P Chanson

4

1 reference

13 February 2018

D Clemmons

5

1 reference

13 February 2018

L A Frohman

6

1 reference

13 February 2018

R Gaillard

7

1 reference

13 February 2018

K Ho

8

1 reference

13 February 2018

P Jaquet

9

1 reference

13 February 2018

D L Kleinberg

10

1 reference

13 February 2018

S W J Lamberts

11

1 reference

13 February 2018

G Lombardi

12

1 reference

13 February 2018

M Sheppard

13

1 reference

13 February 2018

C J Strasburger

14

1 reference

13 February 2018

J A H Wass

16

1 reference

13 February 2018

S Melmed

17

1 reference

13 February 2018

Pituitary Society and the European Neuroendocrine Association

18

1 reference

13 February 2018

publication date

1 December 2003

1 reference

13 February 2018

Journal of Endocrinological Investigation

published in

1 reference

13 February 2018

volume

26

1 reference

13 February 2018

issue

12

1 reference

13 February 2018

page(s)

1242-1247

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1007/bf03349164

exact match

0 references

cites work

Guidelines for acromegaly management

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Decreased regional blood flow in patients with acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Sleep apnea in acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Effects of two different somatostatin analogs on glucose tolerance in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

The prevalence and characteristics of colorectal neoplasia in acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Rheumatic manifestations of pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Somatostatin analogs in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03349164

Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

21 January 2018

1 reference

12 December 2020

The pathology of median neuropathy in acromegaly

1 reference

12 December 2020

1 reference

12 December 2020

Prevalence of hypertension in acromegalic patients: clinical measurement versus 24-hour ambulatory blood pressure monitoring

1 reference

12 December 2020

Tight control of growth hormone: an attainable outcome for acromegaly treatment.

1 reference

12 December 2020

Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide

1 reference

12 December 2020

Hyperproinsulinaemia in acromegaly: evidence for abnormal pancreatic beta-cell function?

1 reference

12 December 2020

Effect of octreotide pretreatment on surgical outcome in acromegaly

1 reference

12 December 2020

Conventional radiotherapy for pituitary tumors.

1 reference

12 December 2020

Acromegaly and hypertension: prevalence and relationship to the renin-angiotensin-aldosterone system

1 reference

12 December 2020

[Bone density of the lumbar spine and femur in acromegaly]

1 reference

12 December 2020

Criteria for cure of acromegaly: a consensus statement

1 reference

12 December 2020

[Prevalence of diabetes in acromegaly and Cushing syndrome]

1 reference

12 December 2020

Acromegaly and cancer: not a problem?

1 reference

12 December 2020

Upper airflow obstruction and pulmonary function in acromegaly: relationship to disease activity.

1 reference

12 December 2020

Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly

1 reference

12 December 2020

Baseline and stimulated catecholamine secretion in normotensive patients with active acromegaly: acute effects of continuous octreotide infusion

1 reference

12 December 2020

Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas

1 reference

12 December 2020

Clinical perspective: acromegaly and cancer: a problem

1 reference

12 December 2020

Pituitary tumor registry: a novel clinical resource

1 reference

12 December 2020

Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03349164

1 reference

13 February 2018

1 reference

13 February 2018